Ligand Pharmaceuticals Incorporated
LGND
$294.60
$5.782.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 454.14% | 273.10% | 186.35% | 202.55% | 7.97% |
| Total Receivables | 58.24% | 26.48% | 59.77% | 44.70% | 35.45% |
| Inventory | -33.74% | -9.22% | -35.34% | -28.91% | -17.05% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -84.54% | -82.37% | -34.31% | -71.22% | 53.64% |
| Total Current Assets | 312.85% | 179.78% | 151.02% | 143.68% | 13.03% |
|
|
|||||
| Total Current Assets | 312.85% | 179.78% | 151.02% | 143.68% | 13.03% |
| Net Property, Plant & Equipment | -15.37% | -2.04% | -25.33% | -56.04% | -54.34% |
| Long-term Investments | 0.00% | 0.00% | -3.52% | -3.52% | -3.52% |
| Goodwill | 0.00% | 0.00% | -3.52% | -3.52% | -3.52% |
| Total Other Intangibles | -16.35% | -15.89% | -15.45% | -15.05% | -11.66% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.46% | 1.61% | 3.89% | 0.44% | 74.24% |
| Total Assets | 130.43% | 69.21% | 65.71% | 54.66% | 9.49% |
|
|
|||||
| Total Accounts Payable | 9.56% | -1.90% | -38.12% | -21.62% | 378.75% |
| Total Accrued Expenses | 95.47% | 39.26% | 13.89% | 56.60% | 54.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.79% | 23.22% | -13.26% | -0.09% | -4.71% |
| Total Finance Division Other Current Liabilities | -83.08% | -84.50% | -20.67% | -12.16% | 587.61% |
| Total Other Current Liabilities | -83.08% | -84.50% | -20.67% | -12.16% | 587.61% |
| Total Current Liabilities | -27.80% | -30.70% | 0.90% | 23.28% | 248.69% |
|
|
|||||
| Total Current Liabilities | -27.80% | -30.70% | 0.90% | 23.28% | 248.69% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -18.41% | 12.01% | -27.86% | -29.55% | -27.84% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -18.65% | -9.29% | -18.73% | -44.16% | -23.43% |
| Total Liabilities | 914.67% | 386.60% | 388.10% | 363.20% | 31.65% |
|
|
|||||
| Common Stock & APIC | 5.89% | 16.63% | 18.75% | 17.22% | 50.13% |
| Retained Earnings | 26.41% | 30.27% | 21.87% | 9.08% | -14.12% |
| Treasury Stock & Other | -47.30% | 444.85% | 242.29% | 433.91% | 1,008.45% |
| Total Common Equity | 16.78% | 25.37% | 22.49% | 12.96% | 6.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.78% | 25.37% | 22.49% | 12.96% | 6.88% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.78% | 25.37% | 22.49% | 12.96% | 6.88% |
|
|
|||||